IGC Pharma (IGC) EBIT Margin (QoQ) (2010 - 2025)
IGC Pharma (IGC) EBIT Margin (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | IGC Pharma | 28.08 Mn | 27.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -93,701.00 |
| Jun 30, 2025 | -15,261.00 |
| Mar 31, 2025 | 30,256.00 |
| Dec 31, 2024 | -30,355.00 |
| Sep 30, 2024 | 45,370.00 |
| Jun 30, 2024 | -14,529.00 |
| Mar 31, 2024 | 73,401.00 |
| Dec 31, 2023 | -61,359.00 |
| Sep 30, 2023 | -47,061.00 |
| Jun 30, 2023 | 204,773.00 |
| Mar 31, 2023 | -174,699.00 |
| Dec 31, 2022 | 54,554.00 |
| Sep 30, 2022 | 9,001.00 |
| Jun 30, 2022 | 400,699.00 |
| Mar 31, 2022 | -364,911.00 |
| Dec 31, 2021 | 608,471.00 |
| Sep 30, 2021 | -491,494.00 |
| Jun 30, 2021 | 59,633.00 |
| Mar 31, 2021 | -129,198.00 |
| Dec 31, 2020 | -81,290.00 |